Vicair (Tablets) Instructions for Use

Instructions
Dosage forms

ATC Code

A02BX (Other drugs for the treatment of gastric and duodenal ulcers and GERD)

Clinical-Pharmacological Group

A drug with antacid, astringent, anti-inflammatory, and antispasmodic action

Pharmacotherapeutic Group

Intestinal antiseptic and astringent

Pharmacological Action

A combined medicinal product that exerts astringent, antacid, laxative, and antispasmodic action.

Bismuth subnitrate forms a protective film on the gastric mucosa, exerting anti-inflammatory, bactericidal, and reparative effects.

Magnesium carbonate reduces the acidity of gastric juice and decreases pepsin activity.

The calamus included in this composition, which has an antispasmodic action, and the buckthorn, which has a laxative action, contribute to the improvement of intestinal transit.

Indications

Use for the treatment of the following gastrointestinal conditions.

Gastric and duodenal ulcer.
Hyperacid gastritis accompanied by constipation.

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
K25	Gastric ulcer
K26	Duodenal ulcer
K27	Peptic ulcer
K29	Gastritis and duodenitis

ICD-11 code	Indication
DA42.Z	Gastritis, unspecified
DA51.Z	Duodenitis, unspecified
DA60.Z	Gastric ulcer, unspecified
DA61	Peptic ulcer of unspecified site
DA63.Z	Duodenal ulcer, unspecified
DA7Z	Diseases of stomach or duodenum, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer orally as tablets.

Take the tablets after meals with a sufficient amount of water.

The typical adult dosage is one to two tablets taken two to three times daily.

Adjust the exact dosage and duration of treatment based on the specific indication, the patient’s age, and the clinical situation.

The maximum daily dose must not be exceeded.

Do not use for more than two months without consulting a physician.

Do not chew the tablets; swallow them whole.

Maintain an interval of at least two hours between the intake of this product and other oral medications, particularly tetracycline antibiotics.

The dosage regimen is individual and must be determined by a healthcare professional.

Adverse Reactions

Possible adverse reactions include loose stools and allergic reactions.

Discontinue use and consult a physician if any adverse reactions occur.

Drug Interactions

Concomitant use with m-cholinoblockers or histamine H₂-receptor blockers may reduce the required dosage of this product.

This product reduces the absorption of tetracycline antibiotics.

Avoid concurrent use with other bismuth-containing medicinal products due to the risk of increased bismuth concentration in the blood.

Contraindications

Do not use under the following conditions.

Hypersensitivity to any component of the combination.
Hypoacid gastritis, chronic appendicitis, or enterocolitis.
Chronic renal failure.
Pregnancy and the lactation period.
Age under 18 years.

Overdose

Symptoms of overdose may be related to the bismuth component, potentially leading to encephalopathy with long-term use of high doses.

In case of suspected overdose, discontinue the product immediately and initiate symptomatic and supportive treatment.

Use in Pregnancy and Lactation

Contraindicated during pregnancy and during the lactation (breastfeeding) period.

Use in Renal Impairment

Contraindicated in chronic renal failure.

Pediatric Use

Contraindicated in children and adolescents under 18 years of age.

Special Precautions

It is necessary to consider the possibility of developing encephalopathy associated with the accumulation of bismuth in the CNS with long-term use in high doses.

During treatment, stools become black in color.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Vicair [Dalkhimpharm, JSC (Russia)]
Tablets: 10 pcs.

Marketing Authorization Holder

Dalkhimpharm, JSC (Russia)

Dosage Form

Vicair

Tablets: 10 pcs.

Dosage Form, Packaging, and Composition

Tablets	1 tab.
Bismuth subnitrate	350 mg
Calamus rhizomes	25 mg
Buckthorn bark	25 mg
Magnesium carbonate	400 mg
Sodium bicarbonate	200 mg

10 pcs. – non-cell contour packaging.
10 pcs. – contour cell packaging.

Vicair [Obnovlenie Pfc, JSC (Russia)]
Tablets: 10, 20, 30, 50, or 100 pcs.

Marketing Authorization Holder

Obnovlenie Pfc, JSC (Russia)

Dosage Form

Vicair

Tablets: 10, 20, 30, 50, or 100 pcs.

Dosage Form, Packaging, and Composition

Tablets	1 tab.
Bismuth subnitrate	350 mg
Marsh calamus rhizomes	25 mg
Buckthorn bark	25 mg
Magnesium carbonate	400 mg
Sodium bicarbonate	200 mg

10 pcs. – non-cell contour packaging (1) – cardboard packs.
10 pcs. – non-cell contour packaging (2) – cardboard packs.
10 pcs. – non-cell contour packaging (3) – cardboard packs.
10 pcs. – non-cell contour packaging (5) – cardboard packs.
10 pcs. – non-cell contour packaging (10) – cardboard packs.

Vicair [Pharmstandard-Tomskkhimpharm OJSC (Russia)]
Tablets: 10, 50, or 100 pcs.

Marketing Authorization Holder

Pharmstandard-Tomskkhimpharm OJSC (Russia)

Manufactured By

Pharmstandard-Lexredstva OJSC (Russia)

Dosage Form

Vicair

Tablets: 10, 50, or 100 pcs.

Dosage Form, Packaging, and Composition

Tablets pink or pinkish-lilac in color with white and dark specks, flat-cylindrical in shape, with a bevel and a score.

	1 tab.
Bismuth subnitrate	0.35 g
Magnesium hydroxycarbonate	0.4 g
Sodium bicarbonate	0.2 g
Buckthorn bark	0.025 g
Calamus rhizomes	0.025 g

Excipients: potato starch – 0.13 g, stearic acid – 0.0048 g, talc – 0.0152 g.

10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
10 pcs. – contour cell packaging (3) – cardboard packs.
10 pcs. – contour cell packaging (5) – cardboard packs.
10 pcs. – contour cell packaging (10) – cardboard packs.

Vicair Avexima [Avexima JSC (Russia)]
Tablets: 10 pcs.